ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for TScan Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:38 am Sale | 2024-12-31 | 13G | TScan Therapeutics, Inc. TCRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,500,000 7.130% | -400,000 (-10.26%) | Filing |
| 2024-02-07 07:45 am Sale | 2023-12-31 | 13G | TScan Therapeutics, Inc. TCRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,900,000 8.960% | -100,000 (-2.50%) | Filing |
| 2023-06-12 4:30 pm Purchase | 2023-05-31 | 13G | TScan Therapeutics, Inc. TCRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,000,000 9.350% | 4,000,000 (New Position) | Filing |